Login / Signup

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.

Luigi MoschiniMarco LoffiValentina RegazzoniGiuseppe Di TanoElisa GherbesiGian Battista Danzi
Published in: Heart and vessels (2020)
Hydroxychloroquine with both ritonavir/darunavir or azithromycin therapy significantly increased the QTc-interval at 7 days. The risk of developing malignant arrhythmias remained relatively low when these drugs were administered for a limited period of time.
Keyphrases
  • hiv infected patients
  • antiretroviral therapy
  • drug induced
  • congenital heart disease
  • respiratory syndrome coronavirus